OnKure Therapeutics (OKUR) Earnings Date, Estimates & Call Transcripts $2.15 -0.08 (-3.59%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock OnKure Therapeutics Earnings Summary Latest Q1 2025 Earnings DateMay. 6EstimatedConsensus EPS (May. 6) -$1.41 Actual EPS (May. 6) -$1.19 Beat By $0.22 OnKure Therapeutics released Q1 2025 earnings on May 6, 2025, reporting an EPS of -$1.19, which topped analysts' consensus estimates of -$1.41 by $0.22. With a trailing EPS of -$6.57, OnKure Therapeutics' earnings are expected to grow next year, from ($4.05) to ($3.41) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Get OnKure Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OnKure Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOKUR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. OnKure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.41-$1.22-$1.32Q2 20252-$1.43-$1.28-$1.36Q3 20252-$1.35-$1.27-$1.31Q4 20252-$1.22-$1.15-$1.19 OnKure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025-$1.41-$1.19+$0.22-$1.19--3/10/2025Q4 2024-$0.86-$1.37 -$0.51-$1.37--11/7/2024Q3 2024-$0.97-$1.10 -$0.13-$1.10--8/13/2024Q2 2024-$1.70-$1.60+$0.10-$1.60--5/7/2024Q1 2024-$3.70-$2.50+$1.20-$2.50--3/28/2024Q4 2023-$5.50-$7.00 -$1.50-$7.00--11/13/2023Q3 2023-$6.00-$5.70+$0.30-$5.70--8/10/2023Q2 2023-$5.50-$6.50 -$1.00-$6.50--5/11/2023Q1 2023-$6.30-$6.00+$0.30-$6.00-- OnKure Therapeutics Earnings - Frequently Asked Questions When did OnKure Therapeutics announce their last quarterly earnings? OnKure Therapeutics (NASDAQ:OKUR) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on OKUR's earnings history. Did OnKure Therapeutics beat their earnings estimates last quarter? In the previous quarter, OnKure Therapeutics (NASDAQ:OKUR) reported ($1.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.41) by $0.22. Learn more on analysts' earnings estimate vs. OKUR's actual earnings. How much profit does OnKure Therapeutics generate each year? OnKure Therapeutics (NASDAQ:OKUR) has a recorded net income of -$77.39 million. OKUR has generated -$6.57 earnings per share over the last four quarters. What is OnKure Therapeutics's EPS forecast for next year? OnKure Therapeutics's earnings are expected to grow from ($4.05) per share to ($3.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies GLSI Earnings FTLF Earnings EDIT Earnings THTX Earnings LYEL Earnings TARA Earnings CGEN Earnings SLS Earnings NMRA Earnings SCPH Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's Earnings This page (NASDAQ:OKUR) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OKUR Stock Free OKUR Stock Alerts